Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
DARA BIOSCIENCES (NQ: DARA)
0.7299 USD  -0.0141 (-1.90%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 0.7500
Bid (Size) 0.7252 (20000)
Ask (Size) 0.7300 (13700)
Prev. Close 0.7440
Today's Range 0.7211 - 0.7500
52wk Range 0.6151 - 1.380
Shares Outstanding 25,000,961
Dividend Yield N/A
Top News
More News
DARA Reports First Quarter 2013 Financial Results and Operational Highlights
May 15, 2013
DARA Management to Host Conference Call and Webcast on Thursday, May 16, 2013 at 9:00 a.m. ET to Provide a Corporate Business Review and Financial Update Read More
from Marketwired News Releases
Helsinn, DARA Announce U.S. Launch of Gelclair
April 22, 2013
The Swiss pharmaceutical Helsinn Group, a leading player in the cancer supportive care arena, announced today that DARA BioSciences, Inc. (NASDAQ: DARA ), a U.S. specialty pharmaceutical company... Read More
category DARA , Benzinga , News , and 1 more.
from Latest Articles from Benzinga.com

More News
Read More
DARA and HELSINN Announce U.S. Launch of Gelclair(R), an FDA-Cleared Oral Gel for the Treatment of Oral Mucositis
April 22, 2013
from Marketwired News Releases
DARA BioSciences (DARA) Enters Distribution Agreement w/ Prime Therapeutics
April 03, 2013
from StreetInsider.com News Articles
DARA BioSciences Enters Into Distribution Agreement for Gelclair(R) and Soltamox(R) With Prime Therapeutics Specialty Pharmacy
April 03, 2013
from Marketwired News Releases
DARA Reports Year-End 2012 Financial Results
April 01, 2013
from Marketwired News Releases
Biotech Industry Looks to Benefit From FDA's New "Breakthrough" Designation
March 20, 2013
from Marketwired News Releases
DARA BioSciences to Present at 25th Annual ROTH Conference
March 18, 2013
from Marketwired News Releases
New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry's Growth in 2012
March 13, 2013
from Marketwired News Releases
A Biotech Triple Play
March 01, 2013
category Pharmaceuticals
from Trefis
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here